Showing results (41-50 of 65) with videos related to
Sort By:
Pageof 7
FEBS Letters|January 27, 2004
Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinaseKiyoshi Komori, Takahiro Nonaka, Akiko Okada, et al.Clinical Pharmacology and Therapeutics|January 17, 2023
Characterizing Granulocytopenia Associated with Thiamazole in Patients with Hyperthyroidism Based on Real-World Data from the MID-NET in JapanYuki Kinoshita, Kazuhiro Kajiyama, Chieko Ishiguro, et al.Journal of Cellular and Molecular Medicine|July 16, 2008
IL-12 immunotherapy of murine leukaemia: comparison of systemic versus gene modified cell therapyAlain Labbe, Megan Nelles, Jagdeep Walia, et al.Journal of Cardiothoracic Surgery|January 8, 2022
Thoracoscopic infrared ablation to create a box lesion as a treatment for atrial fibrillationHiroshi Kubota, Toshiya Ohtsuka, Mikio Ninomiya, et al.Therapeutic Innovation & Regulatory Science|April 19, 2022
Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET® Medical Information Database Network in JapanTomoaki Hasegawa, Sono Sawada, Chieko Ishiguro, et al.The Journal of Dermatological Treatment|July 4, 2024
Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET® in JapanYusuke Okada, Kazuhiro Kajiyama, Chieko Ishiguro, et al.Journal of Bacteriology|February 7, 2023
Structure and Function of Gli123 Involved in Mycoplasma mobile GlidingDaiki Matsuike, Yuhei O Tahara, Takahiro Nonaka, et al.Therapeutic Innovation & Regulatory Science|January 5, 2023
Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical TrialsShinya Watanabe, Takahiro Nonaka, Makoto Maeda, et al.Therapeutic Innovation & Regulatory Science|March 26, 2024
Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy EndpointsShinya Watanabe, Takahiro Nonaka, Makoto Maeda, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 2, 2007
Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growthJosh D Silvertown, Juliane C Symes, Anton Neschadim, et al.Pageof 7